转录因子Sp1在肝细胞癌中的表达

目的通过研究转录因子Sp1在肝细胞癌(HCC)组织中的表达及转化生长因子(TGF)B1对肝癌细胞中Sp1mRNA转录表达的影响,探讨Sp1在HCC中表达的意义及其在细胞凋亡中的作用。方法免疫组织化学方法对51例HCC组织与10例良性病变而切除的正常肝组织中转录因子Sp1进行蛋白检测;体外培养肝癌细胞株HepG2,施加外源性TGFβ1,逆转录一聚合酶链反应方法检测HepG2细胞中Sp1mRNA的表达,并用流式细胞仪检测细胞受到干预后的凋亡情况。结果Sp1蛋白在HCC组织中的表达率明显高于正常肝组织(P〈0.01);施加外源性TGFβ1与对照组相比HepG2细胞Sp1mRNA的表达显著降低(P〈0...

Full description

Saved in:
Bibliographic Details
Published in临床肝胆病杂志 Vol. 29; no. 1; pp. 65 - 67
Main Author 冯洁 汤正好 余永胜
Format Journal Article
LanguageChinese
Published 复旦大学附属上海市第五人民医院消化科,上海,200240%上海交通大学附属第六人民医院感染科,上海,200233 2013
Subjects
Online AccessGet full text
ISSN1001-5256

Cover

More Information
Summary:目的通过研究转录因子Sp1在肝细胞癌(HCC)组织中的表达及转化生长因子(TGF)B1对肝癌细胞中Sp1mRNA转录表达的影响,探讨Sp1在HCC中表达的意义及其在细胞凋亡中的作用。方法免疫组织化学方法对51例HCC组织与10例良性病变而切除的正常肝组织中转录因子Sp1进行蛋白检测;体外培养肝癌细胞株HepG2,施加外源性TGFβ1,逆转录一聚合酶链反应方法检测HepG2细胞中Sp1mRNA的表达,并用流式细胞仪检测细胞受到干预后的凋亡情况。结果Sp1蛋白在HCC组织中的表达率明显高于正常肝组织(P〈0.01);施加外源性TGFβ1与对照组相比HepG2细胞Sp1mRNA的表达显著降低(P〈0.01),且HepG2细胞凋亡率随着TGF[31浓度的增高而上升。结论Sp1蛋白在HCC中的过表达在肿瘤发生发展中起一定作用;TGFβ1诱导肝癌细胞凋亡,而Sp1基因的抑制在TGFβ1诱导肝癌细胞凋亡中可能起一定作用。
Bibliography:Objeaive To determine whether the transcription factor Spl is differentially expressed in human hepatocellular carcinoma (HCC) and to investigate the potential pro - apoptotic effect of transforming growth factor beta 1 ( TGFβ1 ) through Spl by using the HCC cell line HepG2. Methods The Spl expression patterns were detected by immunohistochemistry in tumors from 51 cases of HCC and 10 specimens of normal liver tissues. HepG2 cells in culture were stimulated by TGFβ1 and the change in Spl mRNA expression was detected by RT - PCR while the change in cell apoptosis rate was detected by flow cytometry. Statistical significance of changes were assessed by one -way ANOVA. Results The positive rate of Spl expression was significantly higher in HCC tissue than in normal liver tissues (P 〈 0. 01 ). The level of Spl mRNA was significantly lower in HepG2 cells stimulated with TGFβ1 than in the control cells ( P 〈 0.01 ), and the effect was TGFβ1 dose - dependent. The apoptosis rate of HepG2 ceils increased in cmTesponde
ISSN:1001-5256